SAN ANTONIO, TEXAS -- (Marketwired) -- 10/19/16 -- Nerium Biotechnology, Inc. ("Nerium") announced today the appointment of Kerry Mitchell to its board of directors. Ms. Mitchell has extensive experience as a media executive, with a strong record of building and transforming multi-platform media brands that include some of the most iconic names in Canadian publishing.
"We are very excited to have Ms. Mitchell join Nerium's board of directors," said Dennis Knocke, Nerium's Chief Executive Officer, President and Board Chair. "Her extensive experience in brand development, marketing and sales, including in the cosmetics, fashion and lifestyle industries, will be a great benefit to Nerium."
Ms. Mitchell has been appointed to replace John Christopher Wansbrough, who has resigned from Nerium's board of directors. Dennis Knocke stated that "During the six years that Mr. Wansbrough served on Nerium's board, he provided valuable advice and his contributions to the company are greatly appreciated. We wish him well in all of his future endeavors."
About Nerium Biotechnology, Inc.
Nerium Biotechnology, Inc. is a biotechnology company involved in the research, product development, manufacture and marketing of Nerium oleander-based products. Nerium's shares are not listed on any stock exchange or quotation system.
Forward Looking Statements: Statements made in this news release that relate to future plans, expectations, events or performances are forward looking statements. Such statements are based on current expectations and involve risks and uncertainties.
Nerium Biotechnology, Inc.
Joseph B. Nester
210-822-7908 (ext. 101)